Russell Investments Group
AVLN

Russell Investments Group’s Avalyn Pharma AVLN Stock Holding History

Russell Investments Group’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.1K Buy
+1,369
New +$39.5K ﹤0.01% 3646

Other funds holding AVLN

AP
Andera Partners Paris $206M AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Russell Investments Group's AVLN Position: Q2 2026 in Review

Russell Investments Group opened a new position in Avalyn Pharma (AVLN) in Q2 2026: 1,369 shares worth $45.1K. The stake represents ﹤0.01% of the portfolio and ranks #3646 among its holdings.

11 funds tracked by Wall St. Rank hold AVLN as of Q2 2026.

  • Russell Investments Group held 1,369 shares of Avalyn Pharma worth $45.1K as of Q2 2026.
  • Avalyn Pharma was a new Russell Investments Group position in Q2 2026.
  • Avalyn Pharma made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3646 holding.
  • 11 funds tracked by Wall St. Rank held Avalyn Pharma as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.